Table 2.

Microbiological examinations

	Peripheral blood	Respiratory sample	Feces	Urine	Saliva
04 May	NA	SARS-CoV-2-RNA (-)	Adenovirus Ag (-) Rotavirus Ag (-) Salmonella-Shigella-Campylobacter colture (-)	NA	NA
05 May	SARS-CoV-2-N IgG and IgM (+) SARS-CoV-2-S IgG (+) Enterovirus-RNA (-)	SARS-CoV-2-RNA (low +) Rhinovirus/Enterovirus-RNA (-) Chlamydia pneumonia-DNA (-) Mycoplasma pneumonia-DNA (-) Bordetella pertussis-DNA (-) influenza viruses-RNA (-) respiratory syncytial virus-RNA (-) parainfluenza viruses-RNA (-) human metapneumovirus-RNA (-) adenovirus-DNA (-) middle east respiratory syndrome coronavirus-RNA (-) coronavirus [HKU1, NL63, 229E, OC43]-RNA (-) Enterovirus-RNA (-)	NA	NA	NA
06 May	NA	SARS-CoV-2-RNA (low +)	NA	NA	NA
07 May	CMV-IgG (low +) CMV-IgM (+) MV-IgG (-) MV-IgM (BL) EBV VCA-IgG (-) EBV VCA-IgM (-) Brucella/Salmonella typhi Ab (-) HBs Ag (-) HCV IgG (-) HIV Ag/Ab (-) Blood colture (-)	SARS-CoV-2-RNA (-)	NA	NA	NA
09 May	CMV-DNA (+) [6,095] EBV-DNA (-)	NA	NA	CMV-DNA (+) [1,357] RV-RNA (-) MV-RNA (+)	RV-RNA (-) MV-RNA (+)
11 May	CMV-DNA (+) [4,416] RV IgG (+) RV IgM (-) MV IgG (+) MV IgM (+)	NA	NA	RV-RNA (-) MV-RNA (+)	RV-RNA (-) MV-RNA (+)

(-): negative; (+): positive; BL: borderline; NA: not analyzed; Ig: immunoglobulin; Ag: antigen; Ab: antibody; VCA: viral capsid antigen; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; MV: measles virus; RV: rubella virus; CMV: cytomegalovirus; EBV: Epstain-Barr virus; HBs: hepatitis B surface antigen; HCV: hepatitis C virus; HIV: human immunodeficiency virus; the CMV viral load (copies/mL) was reported in the square brackets